Originator Organization StarkAge TherapeuticsStartup |
Active Organization StarkAge TherapeuticsStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | FR | StarkAge TherapeuticsStartup | 18 Jun 2024 |